These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
711 related items for PubMed ID: 26780494
21. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma. Lubgan D, Rutzner S, Lambrecht U, Rössler K, Buchfelder M, Eyüpoglu I, Fietkau R, Semrau S. J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597 [Abstract] [Full Text] [Related]
24. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M. Neuro Oncol; 2016 Jun; 18(6):863-72. PubMed ID: 26597949 [Abstract] [Full Text] [Related]
25. Malignant meningiomas: a retrospective study of 22 cases. Liu Y, Liu M, Li F, Wu C, Zhu S. Bull Cancer; 2007 Oct; 94(10):E27-31. PubMed ID: 17964977 [Abstract] [Full Text] [Related]
26. Recurrence of intracranial meningioma after surgery: analysis of influencing factors and outcome. Bumrungrachpukdee P, Pruphetkaew N, Phukaoloun M, Pheunpathom N. J Med Assoc Thai; 2014 Apr; 97(4):399-406. PubMed ID: 24964682 [Abstract] [Full Text] [Related]
27. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series. Pessina F, Navarria P, Clerici E, Soffietti R, Nibali MC, Rudà R, Riva M, Scorsetti M, Bello L. World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926 [Abstract] [Full Text] [Related]
30. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, Parsa AT. J Neurosurg; 2010 Nov; 113(5):1029-35. PubMed ID: 20380529 [Abstract] [Full Text] [Related]
31. Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas-5-Year Institutional Experience. Nadeem M, Goyal-Honavar A, Sravya P, Beniwal M, Santosh V, Dwarakanath S. World Neurosurg; 2024 Jul; 187():e331-e339. PubMed ID: 38649022 [Abstract] [Full Text] [Related]
32. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. Keric N, Kalasauskas D, Freyschlag CF, Gempt J, Misch M, Poplawski A, Lange N, Ayyad A, Thomé C, Vajkoczy P, Meyer B, Ringel F. J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826 [Abstract] [Full Text] [Related]
36. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L. J Neurooncol; 2016 Sep; 129(2):337-45. PubMed ID: 27311726 [Abstract] [Full Text] [Related]